Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells

Overview

Journal Cancer Res Commun

Specialty Oncology

Date 2023 Mar 27

PMID 36969743

Authors

Matthew J Martin

Nicolas Floch

Matthias Pfeifer

Steven Criscione

Oona Delpuech

Sladjana Gagrica

Yi Yao

Ultan McDermott

Paul D Smith

Affiliations

Soon will be listed here.

Abstract

Significance: These studies uncover strategies to use targeted agents that activate apoptosis in non-small cell lung cancer cells that survive initial EGFR TKI treatment.

Citing Articles

Drug-tolerant persister cancer cells.

Wang P, Ke B, Ma G J Natl Cancer Cent. 2024; 4(1):1-5.

PMID: 39036383 PMC: 11256673. DOI: 10.1016/j.jncc.2023.12.002.

Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer.

Izumi M, Costa D, Kobayashi S Lung Cancer. 2024; 194:107885.

PMID: 39002493 PMC: 11305904. DOI: 10.1016/j.lungcan.2024.107885.

Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth.

Chen H, Jin W Medicina (Kaunas). 2024; 60(2).

PMID: 38399515 PMC: 10890489. DOI: 10.3390/medicina60020228.

References

Shi P, Oh Y, Deng L, Zhang G, Qian G, Zhang S . Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation. Clin Cancer Res. 2017; 23(21):6567-6579. PMC: 5668147. DOI: 10.1158/1078-0432.CCR-17-1574. View

Deng J, Shimamura T, Perera S, Carlson N, Cai D, Shapiro G . Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion. Cancer Res. 2007; 67(24):11867-75. DOI: 10.1158/0008-5472.CAN-07-1961. View

Friedmann Angeli J, Schneider M, Proneth B, Tyurina Y, Tyurin V, Hammond V . Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014; 16(12):1180-91. PMC: 4894846. DOI: 10.1038/ncb3064. View

Chang C, Jen J, Jiang S, Sayad A, Mer A, Brown K . Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. Cancer Discov. 2021; 12(4):1022-1045. PMC: 8983469. DOI: 10.1158/2159-8290.CD-20-1265. View

Boddu P, Carter B, Verstovsek S, Pemmaraju N . SMAC mimetics as potential cancer therapeutics in myeloid malignancies. Br J Haematol. 2019; 185(2):219-231. DOI: 10.1111/bjh.15829. View

Yecies D, Carlson N, Deng J, Letai A . Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood. 2010; 115(16):3304-13. PMC: 2858493. DOI: 10.1182/blood-2009-07-233304. View

Pham T, Hagenbeek T, Lee H, Li J, Rose C, Lin E . Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways. Cancer Discov. 2020; 11(3):778-793. DOI: 10.1158/2159-8290.CD-20-0706. View

Juin P, Geneste O, Gautier F, Depil S, Campone M . Decoding and unlocking the BCL-2 dependency of cancer cells. Nat Rev Cancer. 2013; 13(7):455-65. DOI: 10.1038/nrc3538. View

Kurppa K, Liu Y, To C, Zhang T, Fan M, Vajdi A . Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Cancer Cell. 2020; 37(1):104-122.e12. PMC: 7146079. DOI: 10.1016/j.ccell.2019.12.006. View

10.

Bolomsky A, Vogler M, Kose M, Heckman C, Ehx G, Ludwig H . MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol. 2020; 13(1):173. PMC: 7731749. DOI: 10.1186/s13045-020-01007-9. View

11.

Hennessy E, Adam A, Aquila B, Castriotta L, Cook D, Hattersley M . Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582). J Med Chem. 2013; 56(24):9897-919. DOI: 10.1021/jm401075x. View

12.

Berger A, Gigi E, Kupershmidt L, Meir Z, Gavert N, Zwang Y . IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy. Nat Cancer. 2022; 2(10):1055-1070. DOI: 10.1038/s43018-021-00261-1. View

13.

Liu Q, Osterlund E, Chi X, Pogmore J, Leber B, Andrews D . Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2. Elife. 2019; 8. PMC: 6414199. DOI: 10.7554/eLife.37689. View

14.

Rehman S, Haynes J, Collignon E, Brown K, Wang Y, Nixon A . Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy. Cell. 2021; 184(1):226-242.e21. PMC: 8437243. DOI: 10.1016/j.cell.2020.11.018. View

15.

Duy C, Li M, Teater M, Meydan C, Garrett-Bakelman F, Lee T . Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence. Cancer Discov. 2021; 11(6):1542-1561. PMC: 8178167. DOI: 10.1158/2159-8290.CD-20-1375. View

16.

Niu X, Zhao J, Ma J, Xie C, Edwards H, Wang G . Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. Clin Cancer Res. 2016; 22(17):4440-51. PMC: 5010519. DOI: 10.1158/1078-0432.CCR-15-3057. View

17.

Dhimolea E, De Matos Simoes R, Kansara D, AlKhafaji A, Bouyssou J, Weng X . An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence. Cancer Cell. 2021; 39(2):240-256.e11. PMC: 8670073. DOI: 10.1016/j.ccell.2020.12.002. View

18.

Su W, Zhang X, Cai X, Peng M, Wang F, Wang Y . BIM deletion polymorphism predicts poor response to EGFR-TKIs in nonsmall cell lung cancer: An updated meta-analysis. Medicine (Baltimore). 2019; 98(10):e14568. PMC: 6417537. DOI: 10.1097/MD.0000000000014568. View

19.

Torres C, Wu M, Hobor S, Wainwright E, Martin M, Patel H . Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis. Nat Commun. 2020; 11(1):1792. PMC: 7156485. DOI: 10.1038/s41467-020-15615-z. View

20.

Osterlund E, Hirmiz N, Pemberton J, Nougarede A, Liu Q, Leber B . Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells. Sci Adv. 2022; 8(16):eabm7375. PMC: 9020777. DOI: 10.1126/sciadv.abm7375. View